In vitro platform of allogeneic stem cell-derived cardiomyocyte transplantation for cardiac conduction defects
EP Europace Journal

Abstract
The aim of the present study is to develop
Cardiomyocytes were derived from rat induced pluripotent stem cells CMs (riPSC-CMs) using an embryoid body-based differentiation method with the serial application of growth factors including activin-A, bone morphogenetic protein 4 (BMP-4), and inhibitor of wnt production 2 (IWP-2). Flow cytometry analysis showed that 74.0 ± 2.7% of riPSC-CMs expressed cardiac troponin-T (
Using an
Contributors

Akira Yoshida
Author

Jong-Kook Lee
Author

Satoki Tomoyama
Author

Keiko Miwa
Author

Keiichi Shirakawa
Author

Sanae Hamanaka
Author

Tomoyuki Yamaguchi
Author

Hiromitsu Nakauchi
Author

Shigeru Miyagawa
Author

Yoshiki Sawa
Author

Issei Komuro
Author

Yasushi Sakata
Author
